• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于CT的透明细胞肾细胞癌肿瘤分级和TNM分期的影像组学分层

CT-based radiomics stratification of tumor grade and TNM stage of clear cell renal cell carcinoma.

作者信息

Demirjian Natalie L, Varghese Bino A, Cen Steven Y, Hwang Darryl H, Aron Manju, Siddiqui Imran, Fields Brandon K K, Lei Xiaomeng, Yap Felix Y, Rivas Marielena, Reddy Sharath S, Zahoor Haris, Liu Derek H, Desai Mihir, Rhie Suhn K, Gill Inderbir S, Duddalwar Vinay

机构信息

College of Medicine - Tucson, University of Arizona, Tucson, AZ, USA.

Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

出版信息

Eur Radiol. 2022 Apr;32(4):2552-2563. doi: 10.1007/s00330-021-08344-4. Epub 2021 Nov 10.

DOI:10.1007/s00330-021-08344-4
PMID:34757449
Abstract

OBJECTIVES

To evaluate the utility of CT-based radiomics signatures in discriminating low-grade (grades 1-2) clear cell renal cell carcinomas (ccRCC) from high-grade (grades 3-4) and low TNM stage (stages I-II) ccRCC from high TNM stage (stages III-IV).

METHODS

A total of 587 subjects (mean age 60.2 years ± 12.2; range 22-88.7 years) with ccRCC were included. A total of 255 tumors were high grade and 153 were high stage. For each subject, one dominant tumor was delineated as the region of interest (ROI). Our institutional radiomics pipeline was then used to extract 2824 radiomics features across 12 texture families from the manually segmented volumes of interest. Separate iterations of the machine learning models using all extracted features (full model) as well as only a subset of previously identified robust metrics (robust model) were developed. Variable of importance (VOI) analysis was performed using the out-of-bag Gini index to identify the top 10 radiomics metrics driving each classifier. Model performance was reported using area under the receiver operating curve (AUC).

RESULTS

The highest AUC to distinguish between low- and high-grade ccRCC was 0.70 (95% CI 0.62-0.78) and the highest AUC to distinguish between low- and high-stage ccRCC was 0.80 (95% CI 0.74-0.86). Comparable AUCs of 0.73 (95% CI 0.65-0.8) and 0.77 (95% CI 0.7-0.84) were reported using the robust model for grade and stage classification, respectively. VOI analysis revealed the importance of neighborhood operation-based methods, including GLCM, GLDM, and GLRLM, in driving the performance of the robust models for both grade and stage classification.

CONCLUSION

Post-validation, CT-based radiomics signatures may prove to be useful tools to assess ccRCC grade and stage and could potentially add to current prognostic models. Multiphase CT-based radiomics signatures have potential to serve as a non-invasive stratification schema for distinguishing between low- and high-grade as well as low- and high-stage ccRCC.

KEY POINTS

• Radiomics signatures derived from clinical multiphase CT images were able to stratify low- from high-grade ccRCC, with an AUC of 0.70 (95% CI 0.62-0.78). • Radiomics signatures derived from multiphase CT images yielded discriminative power to stratify low from high TNM stage in ccRCC, with an AUC of 0.80 (95% CI 0.74-0.86). • Models created using only robust radiomics features achieved comparable AUCs of 0.73 (95% CI 0.65-0.80) and 0.77 (95% CI 0.70-0.84) to the model with all radiomics features in classifying ccRCC grade and stage, respectively.

摘要

目的

评估基于CT的影像组学特征在鉴别低级别(1-2级)透明细胞肾细胞癌(ccRCC)与高级别(3-4级)ccRCC以及低TNM分期(I-II期)ccRCC与高TNM分期(III-IV期)ccRCC中的应用价值。

方法

共纳入587例ccRCC患者(平均年龄60.2岁±12.2;范围22-88.7岁)。其中255个肿瘤为高级别,153个为高分期。对于每位患者,将一个主要肿瘤划定为感兴趣区域(ROI)。然后使用我们机构的影像组学流程,从手动分割的感兴趣体积中,跨12个纹理家族提取2824个影像组学特征。使用所有提取特征(完整模型)以及仅使用先前确定的稳健指标子集(稳健模型)分别开发机器学习模型的不同迭代。使用袋外基尼指数进行变量重要性(VOI)分析,以确定驱动每个分类器的前10个影像组学指标。使用受试者工作特征曲线下面积(AUC)报告模型性能。

结果

区分低级别和高级别ccRCC的最高AUC为0.70(95%CI 0.62-0.78),区分低分期和高分期ccRCC的最高AUC为0.80(95%CI 0.74-0.86)。使用稳健模型进行分级和分期分类时,报告的AUC分别为可比的0.73(95%CI 0.65-0.8)和0.77(95%CI 0.7-0.84)。VOI分析揭示了基于邻域运算的方法(包括灰度共生矩阵(GLCM)、灰度依赖矩阵(GLDM)和灰度游程长度矩阵(GLRLM))在驱动稳健模型进行分级和分期分类性能方面的重要性。

结论

经过验证后,基于CT的影像组学特征可能被证明是评估ccRCC分级和分期的有用工具,并可能为当前的预后模型增添内容。基于多期CT的影像组学特征有潜力作为一种非侵入性分层方案,用于区分低级别和高级别以及低分期和高分期的ccRCC。

关键点

• 从临床多期CT图像中得出的影像组学特征能够区分低级别和高级别ccRCC,AUC为0.70(95%CI 0.62-0.78)。• 从多期CT图像中得出的影像组学特征在ccRCC中具有区分低TNM分期和高TNM分期的判别能力,AUC为0.80(95%CI 0.74-0.86)。• 仅使用稳健影像组学特征创建的模型在对ccRCC进行分级和分期分类时,与使用所有影像组学特征的模型相比,分别实现了可比的AUC,即0.73(95%CI 0.65-0.80)和0.77(95%CI 0.70-0.84)。

相似文献

1
CT-based radiomics stratification of tumor grade and TNM stage of clear cell renal cell carcinoma.基于CT的透明细胞肾细胞癌肿瘤分级和TNM分期的影像组学分层
Eur Radiol. 2022 Apr;32(4):2552-2563. doi: 10.1007/s00330-021-08344-4. Epub 2021 Nov 10.
2
Fuhrman nuclear grade prediction of clear cell renal cell carcinoma: influence of volume of interest delineation strategies on machine learning-based dynamic enhanced CT radiomics analysis.基于 Fuhrman 核分级预测透明细胞肾细胞癌:感兴趣区勾画策略对基于机器学习的动态增强 CT 放射组学分析的影响。
Eur Radiol. 2022 Apr;32(4):2340-2350. doi: 10.1007/s00330-021-08322-w. Epub 2021 Oct 12.
3
Noninvasive Fuhrman grading of clear cell renal cell carcinoma using computed tomography radiomic features and machine learning.使用计算机断层扫描放射组学特征和机器学习对透明细胞肾细胞癌进行无创富尔曼分级。
Radiol Med. 2020 Aug;125(8):754-762. doi: 10.1007/s11547-020-01169-z. Epub 2020 Mar 19.
4
Development and validation of a CT-based nomogram for preoperative prediction of clear cell renal cell carcinoma grades.基于CT的列线图用于术前预测透明细胞肾细胞癌分级的开发与验证
Eur Radiol. 2021 Aug;31(8):6078-6086. doi: 10.1007/s00330-020-07667-y. Epub 2021 Jan 29.
5
Predicting the ISUP grade of clear cell renal cell carcinoma with multiparametric MR and multiphase CT radiomics.基于多参数 MRI 和多期 CT 影像组学预测透明细胞肾细胞癌的 ISUP 分级。
Eur Radiol. 2020 May;30(5):2912-2921. doi: 10.1007/s00330-019-06601-1. Epub 2020 Jan 30.
6
Deep learning and radiomics: the utility of Google TensorFlow™ Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT.深度学习和放射组学:Google TensorFlow™ Inception 在多期 CT 上对透明细胞肾细胞癌和嗜酸细胞瘤分类的应用。
Abdom Radiol (NY). 2019 Jun;44(6):2009-2020. doi: 10.1007/s00261-019-01929-0.
7
Study of radiomics based on dual-energy CT for nuclear grading and T-staging in renal clear cell carcinoma.基于双能 CT 的影像组学在肾透明细胞癌核分级和 T 分期中的研究。
Medicine (Baltimore). 2024 Mar 8;103(10):e37288. doi: 10.1097/MD.0000000000037288.
8
CT-based peritumoral radiomics signatures for malignancy grading of clear cell renal cell carcinoma.基于 CT 的肿瘤周围放射组学特征用于肾透明细胞癌的恶性程度分级。
Abdom Radiol (NY). 2021 Jun;46(6):2690-2698. doi: 10.1007/s00261-020-02890-z. Epub 2021 Jan 11.
9
Juxtatumoral perinephric fat analysis in clear cell renal cell carcinoma.肾透明细胞癌瘤周肾周脂肪分析。
Abdom Radiol (NY). 2019 Apr;44(4):1470-1480. doi: 10.1007/s00261-018-1848-x.
10
CT-based radiomic model predicts high grade of clear cell renal cell carcinoma.基于 CT 的放射组学模型预测肾透明细胞癌高级别。
Eur J Radiol. 2018 Jun;103:51-56. doi: 10.1016/j.ejrad.2018.04.013. Epub 2018 Apr 11.

引用本文的文献

1
Oral contrast-enhanced ultrasonographic features and radiomics analysis to predict NIH risk stratification for gastrointestinal stromal tumors.口服对比增强超声特征及影像组学分析预测胃肠道间质瘤的美国国立卫生研究院风险分层
Front Oncol. 2025 Jul 3;15:1590432. doi: 10.3389/fonc.2025.1590432. eCollection 2025.
2
Prediction of PD-L1 and CD68 in Clear Cell Renal Cell Carcinoma with Green Learning.利用绿色学习法预测透明细胞肾细胞癌中的PD-L1和CD68
J Imaging. 2025 Jun 10;11(6):191. doi: 10.3390/jimaging11060191.
3
Subregion-based radiomics analysis for predicting the histological grade of clear cell renal cell carcinoma.

本文引用的文献

1
Computed Tomography-Based Radiomics Model for Predicting the WHO/ISUP Grade of Clear Cell Renal Cell Carcinoma Preoperatively: A Multicenter Study.基于计算机断层扫描的放射组学模型术前预测透明细胞肾细胞癌WHO/ISUP分级:一项多中心研究
Front Oncol. 2021 Feb 25;11:543854. doi: 10.3389/fonc.2021.543854. eCollection 2021.
2
Validation of the World Health Organization/International Society of Urological Pathology grading for Chinese patients with clear cell renal cell carcinoma.世界卫生组织/国际泌尿病理学会分级系统在中国透明细胞肾细胞癌患者中的验证
Transl Androl Urol. 2020 Dec;9(6):2665-2674. doi: 10.21037/tau-20-799.
3
基于亚区域的放射组学分析预测透明细胞肾细胞癌的组织学分级
Front Oncol. 2025 May 27;15:1554830. doi: 10.3389/fonc.2025.1554830. eCollection 2025.
4
Non-invasive prediction of nuclear grade in renal cell carcinoma using CT-Based radiomics: a systematic review and meta-analysis.基于CT的放射组学对肾细胞癌核分级的无创预测:一项系统评价和荟萃分析
Abdom Radiol (NY). 2025 Jun 11. doi: 10.1007/s00261-025-05056-x.
5
Enhanced staging of renal cell carcinoma using tumor morphology features: model development and multi-source validation.利用肿瘤形态学特征增强肾细胞癌分期:模型开发与多源验证
NPJ Digit Med. 2025 May 24;8(1):305. doi: 10.1038/s41746-025-01723-x.
6
A CT-based intratumoral and peritumoral radiomics nomogram for postoperative recurrence risk stratification in localized clear cell renal cell carcinoma.基于CT的瘤内和瘤周影像组学列线图用于局部透明细胞肾细胞癌术后复发风险分层
BMC Med Imaging. 2025 May 16;25(1):167. doi: 10.1186/s12880-025-01715-z.
7
CT-based AI framework leveraging multi-scale features for predicting pathological grade and Ki67 index in clear cell renal cell carcinoma: a multicenter study.基于CT的人工智能框架利用多尺度特征预测透明细胞肾细胞癌的病理分级和Ki67指数:一项多中心研究
Insights Imaging. 2025 May 14;16(1):102. doi: 10.1186/s13244-025-01980-0.
8
The interpretable CT-based vision transformer model for preoperative prediction of clear cell renal cell carcinoma SSIGN score and outcome.基于可解释CT的视觉Transformer模型用于术前预测透明细胞肾细胞癌SSIGN评分及预后。
Insights Imaging. 2025 May 9;16(1):98. doi: 10.1186/s13244-025-01972-0.
9
ASO Author Reflections: CT-Based Radiomics for Pathological T Staging in Clear Cell Renal Cell Carcinoma: Insights from Intratumoral and Peritumoral Features.ASO作者反思:基于CT的放射组学在透明细胞肾细胞癌病理T分期中的应用:来自肿瘤内和肿瘤周围特征的见解
Ann Surg Oncol. 2025 Aug;32(8):6191-6192. doi: 10.1245/s10434-025-17174-3. Epub 2025 May 5.
10
Radiomics-clinical nomogram for preoperative tumor-node-metastasis staging prediction in breast cancer patients using dynamic enhanced magnetic resonance imaging.基于动态增强磁共振成像的乳腺癌患者术前肿瘤-淋巴结-转移分期预测的影像组学-临床列线图
Transl Cancer Res. 2025 Mar 30;14(3):1836-1848. doi: 10.21037/tcr-24-1559. Epub 2025 Mar 18.
Identification of robust and reproducible CT-texture metrics using a customized 3D-printed texture phantom.
使用定制的 3D 打印纹理体模识别稳健且可重复的 CT 纹理指标。
J Appl Clin Med Phys. 2021 Feb;22(2):98-107. doi: 10.1002/acm2.13162. Epub 2021 Jan 12.
4
Clinical use of a machine learning histopathological image signature in diagnosis and survival prediction of clear cell renal cell carcinoma.机器学习组织病理学图像特征在透明细胞肾细胞癌诊断和生存预测中的临床应用
Int J Cancer. 2021 Feb 1;148(3):780-790. doi: 10.1002/ijc.33288. Epub 2020 Sep 17.
5
Shape and texture-based radiomics signature on CT effectively discriminates benign from malignant renal masses.基于形状和纹理的 CT 放射组学特征可有效区分良恶性肾肿块。
Eur Radiol. 2021 Feb;31(2):1011-1021. doi: 10.1007/s00330-020-07158-0. Epub 2020 Aug 15.
6
Magnetic Resonance Imaging Radiomics Analyses for Prediction of High-Grade Histology and Necrosis in Clear Cell Renal Cell Carcinoma: Preliminary Experience.磁共振成像放射组学分析预测肾透明细胞癌高级别组织学和坏死:初步经验。
Clin Genitourin Cancer. 2021 Feb;19(1):12-21.e1. doi: 10.1016/j.clgc.2020.05.011. Epub 2020 May 23.
7
Development and External Validation of Radiomics Approach for Nuclear Grading in Clear Cell Renal Cell Carcinoma.基于影像组学的肾透明细胞癌核分级模型的建立与外部验证
Ann Surg Oncol. 2020 Oct;27(10):4057-4065. doi: 10.1245/s10434-020-08255-6. Epub 2020 May 18.
8
A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma.一种基于9个长链非编码RNA特征的列线图,用于改善透明细胞肾细胞癌的预后预测。
Cancer Cell Int. 2019 Aug 5;19:208. doi: 10.1186/s12935-019-0928-5. eCollection 2019.
9
Reliability of CT-based texture features: Phantom study.基于 CT 的纹理特征的可靠性:体模研究。
J Appl Clin Med Phys. 2019 Aug;20(8):155-163. doi: 10.1002/acm2.12666. Epub 2019 Jun 20.
10
Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvement.重新审视美国癌症联合委员会(AJCC)肾细胞癌TNM分期:寻求改进
Ann Transl Med. 2019 Mar;7(Suppl 1):S18. doi: 10.21037/atm.2019.01.50.